Key result
Proximal STEMI lesions are linked to a ~10% lower LVEF versus nonproximal lesions.
Why the study?
Coronary occlusion location significantly affects prognosis in STEMI, but the association between culprit lesion location and underlying risk factors needed assessment.
Does proximal culprit lesion location associate with lower LVEF or specific risk factors in patients with STEMI?
Observational (n=212)
Does proximal culprit lesion location associate with lower LVEF or specific risk factors in patients with STEMI?
Absolute Event Rate: 35.5% vs 45%
p-value: p=< 0.001
Proximal culprit lesions in STEMI are associated with worse left ventricular systolic function compared to nonproximal lesions, independent of baseline risk factors.
May prompt enhanced LV surveillance in proximal STEMI; leaves open whether lesion location independently affects prognosis or therapy response.
Context: ST-elevation myocardial infarction (STEMI) is a critical manifestation of coronary artery disease characterized by sudden and complete occlusion of a coronary artery. The location of the occlusion significantly affects the patient’s prognosis. Aims: This study aims to assess the location of lesions in STEMI patients and their association with underlying risk factors. Settings and Design: This prospective observational study was conducted from July 2021 to November 2023. Subjects and Methods: Patients of both sexes, over 18, with STEMI who underwent primary percutaneous coronary intervention (PCI) or PCI within 24 h after fibrinolytic therapy were included in the study. The patients’ angiographic data were reviewed, and the locations of the culprit lesions were classified as proximal or nonproximal. Statistical Analysis Used: The Student’s t -test or Mann–Whitney U -test and one-way ANOVA or Kruskal–Wallis were used for comparisons by SPSS. Statistical significance was considered P < 0.05. Results: There were 212 patients for analysis. Of 212 patients (25–86 years, 88.7% male), 40.1% had proximal lesions with a lower left ventricular ejection fraction (LVEF) compared to nonproximal lesions (35.5 [31.88–45] vs. 45 [40–50], P < 0.001). Diabetes mellitus (DM), hypertension, and smoking histories were present in 19.9%, 36.2%, and 49.0%, respectively. There was no significant difference in proximal versus nonproximal culprit lesions according to risk factors. Conclusions: Patients diagnosed with STEMI and proximal coronary lesions have lower LVEF compared to those with nonproximal lesions. There was no significant association between culprit lesion location and risk factors, including sex, hypertension, DM, dyslipidemia, body mass index, smoking, and age.
No takes yet. Share an insight, caveat, or question.
Gheydari et al. (2025) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=212). Proximal culprit lesions vs. Nonproximal culprit lesions was evaluated on Left ventricular ejection fraction (LVEF) (p=< 0.001). Patients with STEMI and proximal coronary lesions had a significantly lower left ventricular ejection fraction compared to those with nonproximal lesions (35.5 vs. 45; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: